Andrew Perry - May 10, 2023 Form 4 Insider Report for G1 Therapeutics, Inc. (GTHX)

Role
Chief Commercial Officer
Signature
/s /Sandi James, attorney-in-fact
Stock symbol
GTHX
Transactions as of
May 10, 2023
Transactions value $
$0
Form type
4
Date filed
5/12/2023, 04:19 PM
Previous filing
Jan 5, 2023
Next filing
Jul 7, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GTHX Common Stock Award $0 +35K +164.32% $0.00 56.3K May 10, 2023 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a restricted stock unit ("RSU") award that vests 50% on May 10, 2024 and 50% on May 10, 2025, subject to the Reporting Person's continued service through each applicable vesting date.
F2 Each RSU represents a contingent right to receive one share of Issuer common stock.
F3 Represents (i) 700 shares of common stock; (ii) 4,500 RSUs from award granted on January 3, 2022; (iii) 16,100 RSUs from award granted on January 3, 2023, and (iv) 35,000 RSUs from award granted on May 10, 2023.